Evidence map›Paper›PMID 18644891›Full record

ArticleThe Journal of cell biology2008

Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB.

Kai-Fu Tang, Hong Ren, Jia Cao, Gui-Li Zeng, Jing Xie, Min Chen, Lu Wang, Cai-Xia He

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Upregulation of FAM50A promotes cancer development.Medical oncology (Northwood, London, England) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Aging mechanisms-A perspective mostly fromAdvanced genetics (Hoboken, N.J.) · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kai-Fu TangKey Laboratory of Molecular Biology for Infectious Diseases of the State Ministry of Education, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People's Republic of China. tang_kaifu@yahoo.com.cn
Hong Ren
Jia Cao
Gui-Li Zeng
Jing Xie
Min Chen
Lu Wang
Cai-Xia He
Second Affiliated Hospital of Chongqing Medical University · CNArmy Medical University · CNChongqing Medical University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA interference (RNAi) acts constitutively to silence the innate immune response, and innate immunity genes are misregulated in Dicer-deficient Caenorhabditis elegans. Here, we show that inhibition of Dicer expression by RNAi in human cells up-regulates major histocompatibility complex class I-related molecules A and B (MICA and MICB). MICA and MICB are innate immune system ligands for the NKG2D receptor expressed by natural killer cells and activated CD8(+)T cells. We reveal that knockdown of Dicer elicits DNA damage. Up-regulation of MICA and MICB by Dicer knockdown is prevented by pharmacologic or genetic inhibition of DNA damage pathway components, including ataxia telangiectasia mutated (ATM) kinase, ATM- and Rad3-related kinase, or checkpoint kinase 1. Therefore we conclude that up-regulation of MICA and MICB is the result of DNA damage response activation caused by Dicer knockdown. Our results suggest that RNAi is indirectly linked to the human innate immune system via the DNA damage pathway.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCaenorhabditis elegans ProteinsCell Cycle ProteinsCell LineCheckpoint Kinase 1Checkpoint Kinase 2DEAD-box RNA HelicasesDNA-Binding ProteinsDNA DamageDown-RegulationEndoribonucleasesHistocompatibility Antigens Class IHumansImmunity, InnateNK Cell Lectin-Like Receptor Subfamily KProtein KinasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanCaenorhabditis elegans ProteinsCell Cycle ProteinsCheckpoint Kinase 1Checkpoint Kinase 2CHEK1 protein, humanchk-1 protein, C elegansDEAD-box RNA HelicasesDICER1 protein, humanDNA-Binding ProteinsEndoribonucleasesHistocompatibility Antigens Class IKLRK1 protein, humanMHC class I-related chain AMICB antigenNK Cell Lectin-Like Receptor Subfamily KProtein KinasesProtein Serine-Threonine Kinasesrad3 protein, S pombeReceptors, ImmunologicReceptors, Natural Killer CellRibonuclease IIISchizosaccharomyces pombe ProteinsTumor Suppressor Proteins

Identifiers

PMID18644891
PMCPMC2483517
OpenAlexW2096211844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.